Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Myth-buster

Vitamin D supplements in overweight children were linked to a drop in 'good' HDL cholesterol — the only cardiometabolic marker that budged at all.

This small, low-quality meta-analysis of just 3 studies found that vitamin D actually lowered HDL cholesterol in overweight kids, but the overall evidence is too weak and contradictory to say vitamin D is harmful — it just means the popular idea that it automatically improves heart health in this group is now contested.

In a meta-analysis of 440 overweight children and adolescents, vitamin D supplementation didn't improve any of the eight cardiometabolic risk factors measured — including body mass index, blood sugar, insulin, and triglycerides. The only significant change was a small reduction in HDL (the 'good' cholesterol), which is the opposite of what many people expect from vitamin D.

Where this fits in the evidence

Pillser has synthesized 3 studies on Vitamin D for Increased HDL Cholesterol Levels — overall evidence strength: Very low.

Across 3 studies, 1 reported a small beneficial effect of vitamin D on increasing HDL cholesterol levels in pediatric patients with MASLD, 1 reported a small harmful effect (reducing HDL-C) in obese/overweight children and adolescents, and 1 reported no significant association. The evidence is conflicting, and the predominant effect size is small but inconsistent. No consistent dose or form emerged across studies.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top